2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.

Ann Rheum Dis.

Götestam Skorpen C, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C, da Silva J, Nelson-Piercy C, Cetin I, Costedoat-Chalumeau N, Dolhain R, Förger F, Khamashta M, Ruiz-Irastorza G, Zink A, Vencovsky J, Cutolo M, Caeyers N, Zumbühl C, Østensen M

doi: 10.1136/

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases

Ann Rheum Dis.

Gossec L, Kedra J, Servy H, Pandit A, Stones S, Berenbaum F, Finckh A, Baraliakos X, Stamm TA, Gomez-Cabrero D, Pristipino C, Choquet R, Burmester GR, Radstake TRDJ

doi: 10.1136/annrheumdis-

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-analysis

Arthritis Rheumatol.

Putman M, Chock YPE, Tam H, Kim AHJ, Sattui SE, Berenbaum F, Danila MI, Korsten P, Sanchez-Alvarez C, Sparks JA, Coates LC, Palmerlee C, Peirce A, Jayatilleke A, Johnson SR, Kilian A, Liew J, Prokop LJ, Murad MH, Grainger R, Wallace ZS, Duarte-García A, COVID-19 Global Rheumatology Alliance

doi: 10.1002/art.41469.

Further Publications Rheumatology

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

RMD Open

Sattui SE, Liew JW, Kennedy K, Sirotich E, Putman M, Moni TT, Akpabio A, Alpízar-Rodríguez D, Berenbaum F, Bulina I, Conway R, Singh AD, Duff E, Durrant KL, Gheita TA, Hill CL, Howard RA, Hoyer BF, Hsieh E, El Kibbi L, Kilian A, Kim AH, Liew DFL, Lo C, Miller B, Mingolla S, Nudel M, Palmerlee CA, Singh JA, Singh N, Ugarte-Gil MF, Wallace J, Young KJ, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Harrison C, Larché M, Levine M, Foster G, Thabane L, Rider LG, Hausmann JS, Simard JF, Sparks JA

doi: 10.1136/rmdopen-2021-001814

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

COVID-19 and Rheumatology patients on immunomodulatory therapy - can we extrapolate data from previous viral pandemics?

J Rheumatol.

Jethwa H, Sullivan A, Abraham S

doi: 10.3899/jrheum.200527.

Psoriasis

National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 2 - Advances in Psoriatic Disease Management, COVID-19 Vaccines, and COVID-19 Treatments

J Am Acad Dermatol

Gelfand JM, Armstrong AW, Bell S, Anesi GL, Blauvelt A, Calabrese C, Dommasch ED, Feldman SR, Gladman D, Kircik L, Lebwohl M, Lo Re V 3rd, Martin G, Merola JF, Scher JU, Schwartzman S, Treat JR, Van Voorhees AS, Ellebrecht CT, Fenner J, Ocon A, Syed MN, Weinstein EJ, Gondo G, Heydon S, Koons S, Ritchlin CT

doi: 10.1016/j.jaad.2020.12.058

SPECIAL REPORT

Rheumatoid Arthritis

EULAR 2021

Further Publications Rheumatology

EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis

Ann Rheum Dis

Nagy G, Roodenrijs NMT, Welsing PMJ, Kedves M, Hamar A, van der Goes MC, Kent A, Bakkers M, Pchelnikova P, Blaas E, Senolt L, Szekanecz Z, Choy EH, Dougados M, Jacobs JW, Geenen R, Bijlsma JW, Zink A, Aletaha D, Schoneveld L, van Riel P, Dumas S, Prior Y, Nikiphorou E, Ferraccioli G, Schett G, Hyrich KL, Mueller-Ladner U, Buch MH, McInnes IB, van der Heijde D, van Laar JM

doi: 10.1136/annrheumdis-2021-220973

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Capturing patient-reported outcomes during the COVID-19 pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey

Arthritis Care Res (Hoboken).

Sirotich E, Dillingham S, Grainger R, Hausmann JS, COVID-19 Global Rheumatology Alliance Steering Committee.

doi: 10.1002/acr.24257.

Related content

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.

EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases

Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-analysis

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

COVID-19 and Rheumatology patients on immunomodulatory therapy - can we extrapolate data from previous viral pandemics?

National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 2 - Advances in Psoriatic Disease Management, COVID-19 Vaccines, and COVID-19 Treatments

EULAR 2021

EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis

Capturing patient-reported outcomes during the COVID-19 pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey